Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on June 17, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Nyxoah Receives $15 Million from the European Investment Bank
Nyxoah Reçoit 15 Millions de Dollars de la Banque Européenne d’Investissement
Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States
PruittHealth Expands Home Health Presence in South Georgia
THY Precision Delivers Precision Plastic Injection Molds for Silicone Hydrogel Contact Lens Manufacturing
Australia's most vulnerable treated as the vegemite between a slice of State and Federal Government
Ontario Shores partners with community organizations to bring dementia care training to families
University of East-West Medicine Celebrates Inaugural Professional Doctorate Graduation Ceremony
Nova Southeastern University Opens Nevada Campus to Address Growing Need for Healthcare Professionals in the Region
Banner Health welcomes new executive to grow access, value-based care across multi-state system
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042
Le brevet d’AB Science concernant le masitinib dans le traitement du cancer de la prostate métastatique hormono-résistant a été officiellement délivré aux Etats-Unis avec une durée de protection jusqu’en 2042
RESTEM to Present at BIO International Convention
Applied Biologics Announces Completion of Planned Enrollment Activities in the CAMPX Randomized Controlled Trial Evaluating XWRAP®
CTD-ILD Enters New Treatment Era, but Physicians Still See Significant Unmet Need

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.